Short answer
Inmune Bio, Inc. (INMB) filed an 8-K current report with the SEC on June 17, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Item 5.02 indicates potential leadership or board changes at Inmune Bio.
Inmune Bio, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Item 5.02 indicates potential leadership or board changes at Inmune Bio
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All five director nominees re-elected, with 5,955,609–7,508,310 votes for each
- CBIZ CPAs P.C. auditor appointment ratified for fiscal year ending December 31, 2026, with 17,293,255 votes for
- Third Amended and Restated 2021 Stock Incentive Plan approved, with 6,085,086 votes for
- Plan approval authorizes continued equity-based compensation, creating potential shareholder dilution
- 8,501,317 broker non-votes affected director and incentive-plan tallies but not auditor ratification
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Inmune Bio, Inc. 8-K filings
Get the next INMB 8-K as it lands
Follow INMB for push alerts, or ask the research agent what this filing means.